Detalhe da pesquisa
1.
Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial.
J Am Acad Dermatol
; 90(2): 395-397, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804933